A detailed history of National Bank Of Canada transactions in Profound Medical Corp. stock. As of the latest transaction made, National Bank Of Canada holds 121,837 shares of PROF stock, worth $916,214. This represents 0.0% of its overall portfolio holdings.

Number of Shares
121,837
Previous 121,837 -0.0%
Holding current value
$916,214
Previous $969,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.47 - $11.18 $48,054 - $71,920
-6,433 Reduced 5.02%
121,837 $969,000
Q2 2024

Aug 02, 2024

BUY
$7.25 - $9.07 $1,747 - $2,185
241 Added 0.19%
128,270 $1.08 Million
Q1 2024

May 13, 2024

BUY
$7.3 - $9.46 $9,497 - $12,307
1,301 Added 1.03%
128,029 $1.09 Million
Q4 2023

Feb 06, 2024

SELL
$7.85 - $11.18 $11,092 - $15,797
-1,413 Reduced 1.1%
126,728 $1.08 Million
Q3 2023

Oct 10, 2023

BUY
$7.91 - $13.27 $19,442 - $32,617
2,458 Added 1.96%
128,141 $1.31 Million
Q2 2023

Jul 26, 2023

SELL
$9.27 - $14.88 $15,239 - $24,462
-1,644 Reduced 1.29%
125,683 $1.64 Million
Q1 2023

Apr 12, 2023

SELL
$8.85 - $13.27 $6.83 Million - $10.2 Million
-772,150 Reduced 85.84%
127,327 $1.18 Million
Q4 2022

Jan 24, 2023

BUY
$3.18 - $10.91 $8,741 - $29,991
2,749 Added 0.31%
899,477 $0
Q3 2022

Oct 13, 2022

BUY
$3.99 - $9.3 $3.11 Million - $7.24 Million
778,386 Added 657.74%
896,728 $3.74 Million
Q2 2022

Jul 28, 2022

BUY
$6.34 - $9.53 $29,969 - $45,048
4,727 Added 4.16%
118,342 $840,000
Q1 2022

May 05, 2022

BUY
$8.16 - $11.33 $277,072 - $384,710
33,955 Added 42.62%
113,615 $1.02 Million
Q4 2021

Jan 24, 2022

BUY
$10.38 - $15.2 $826,870 - $1.21 Million
79,660 New
79,660 $722,000

Others Institutions Holding PROF

About Profound Medical Corp.


  • Ticker PROF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,851,300
  • Market Cap $157M
  • Description
  • Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...
More about PROF
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.